7,054 Matching Annotations
  1. Sep 2020
    1. sgtro=action Diseñar este ejercicio para que resuman los puntos clave de escribir un artiulo

    1. ac:agregar todos los materiales de este portal a bioinformacion y bioinfovestigacion

    1. Este es un ejemplo de recuperación de literatura en el que difícilmente tendré una consulta útil, por lo tanto la estrategia es usar documentos tipo y obtener los relacionados con base en revista, autor, referencias y citas.,

      Estrategia:aguja en un pajar.

      Cuál es la mejor base de datos para seguir esta estrategia?

    1. What type of research article is this?What information tells you this?Later, questions using the same published articles become more complex: How do you know this study is trustworthy?The author states this is an experimental study. Explain the details that make it experimental.

      Diseñar preguntas así sobre un articulo!!! preguntar a los alumnos que preguntas harían?

    1. Highlights are three to five (three to four for Cell Press articles) result-oriented points that provide readers with an at-a-glance overview of the main findings of your article. Think of them as a quick snippet of the results—short and sweet. Each Highlight must be 85 characters or fewer, including spaces, and the Highlights together must clearly convey only the results of the study. Ideas, concepts and methods are best saved for the abstract or “In Brief” paragraph (currently in Cell Press journals only). Don't try to capture every piece of data or conclusion. Let the paper do the talking.Highlights offer your paper an advantage in the online world. At a glance, readers can view the results of a manuscript and quickly identify what they want to read, without having to dig through abstracts. The more eyes scanning your Highlights, the easier it is for readers to discover something they might not have stumbled upon otherwise.

      agregar a presentacion, definir termino en ontologia, revisar,prioridad1

      puntos_destacados/Los puntos destacados son de tres a cinco (tres a cuatro para los artículos de Cell Press) orientados a resultados que brindan a los lectores una visión general de los principales hallazgos de su artículo. Piense en ellos como un breve fragmento de los resultados, cortos y dulces. Cada resaltado debe tener 85 caracteres o menos, incluidos los espacios, y los resaltados juntos deben transmitir claramente solo los resultados del estudio. Las ideas, conceptos y métodos se guardan mejor para el resumen o el párrafo “En breve” (actualmente solo en revistas de Cell Press). No intente capturar cada dato o conclusión. Deja que el papel hable.

      Lo más destacado ofrece a su papel una ventaja en el mundo en línea. De un vistazo, los lectores pueden ver los resultados de un manuscrito e identificar rápidamente lo que quieren leer, sin tener que revisar los resúmenes. Cuantos más ojos escudriñen sus Aspectos destacados, más fácil será para los lectores descubrir algo con lo que quizás no se hayan topado.

    1. In conclusion, PubMed citations come from 1) MEDLINE indexed journals, 2) journals/manuscripts deposited in PMC, and 3) NCBI Bookshelf. Both MEDLINE and other PubMed citations may have links to full-text articles or manuscripts in PMC, NCBI Bookshelf, and publishers' Web sites. If you limit your PubMed search to MeSH controlled vocabulary or the MEDLINE subset, you will see only MEDLINE citations in your results.

      Hacer un diagrama con conjuntos para ilustrar esto.

    1. MeSH Vocabulary Changes:

      Cambios/actualizaciones en MeSH

    1. A single list can and should be used for both purposes.

      Una lista dos propósitos.

    1. Search results

      Resultados de la búsqueda Término (s): Pulmonary hypertension

    2. Create RSS

      Opción para crear RSS en mi búsqueda

    3. Filters: Manage Filters Sort by:Best matchMost recentResults by year1920Year 1925 - 1 itemsYear 1926 - 0 itemsYear 1927 - 0 itemsYear 1928 - 0 itemsYear 1929 - 0 items1930Year 1930 - 0 itemsYear 1931 - 0 itemsYear 1932 - 0 itemsYear 1933 - 0 itemsYear 1934 - 1 itemsYear 1935 - 0 itemsYear 1936 - 0 itemsYear 1937 - 0 itemsYear 1938 - 0 itemsYear 1939 - 0 items1940Year 1940 - 2 itemsYear 1941 - 0 itemsYear 1942 - 1 itemsYear 1943 - 0 itemsYear 1944 - 0 itemsYear 1945 - 3 itemsYear 1946 - 10 itemsYear 1947 - 13 itemsYear 1948 - 20 itemsYear 1949 - 17 items1950Year 1950 - 45 itemsYear 1951 - 86 itemsYear 1952 - 94 itemsYear 1953 - 82 itemsYear 1954 - 81 itemsYear 1955 - 71 itemsYear 1956 - 98 itemsYear 1957 - 125 itemsYear 1958 - 160 itemsYear 1959 - 147 items1960Year 1960 - 124 itemsYear 1961 - 131 itemsYear 1962 - 176 itemsYear 1963 - 260 itemsYear 1964 - 398 itemsYear 1965 - 245 itemsYear 1966 - 221 itemsYear 1967 - 278 itemsYear 1968 - 283 itemsYear 1969 - 325 items1970Year 1970 - 314 itemsYear 1971 - 341 itemsYear 1972 - 352 itemsYear 1973 - 300 itemsYear 1974 - 323 itemsYear 1975 - 329 itemsYear 1976 - 354 itemsYear 1977 - 332 itemsYear 1978 - 329 itemsYear 1979 - 381 items1980Year 1980 - 435 itemsYear 1981 - 426 itemsYear 1982 - 440 itemsYear 1983 - 502 itemsYear 1984 - 571 itemsYear 1985 - 569 itemsYear 1986 - 590 itemsYear 1987 - 576 itemsYear 1988 - 640 itemsYear 1989 - 758 items1990Year 1990 - 707 itemsYear 1991 - 777 itemsYear 1992 - 726 itemsYear 1993 - 787 itemsYear 1994 - 784 itemsYear 1995 - 887 itemsYear 1996 - 881 itemsYear 1997 - 934 itemsYear 1998 - 999 itemsYear 1999 - 965 items2000Year 2000 - 976 itemsYear 2001 - 1,098 itemsYear 2002 - 1,060 itemsYear 2003 - 1,112 itemsYear 2004 - 1,321 itemsYear 2005 - 1,491 itemsYear 2006 - 1,555 itemsYear 2007 - 1,672 itemsYear 2008 - 1,731 itemsYear 2009 - 1,884 items2010Year 2010 - 2,082 itemsYear 2011 - 2,151 itemsYear 2012 - 2,392 itemsYear 2013 - 2,699 itemsYear 2014 - 2,937 itemsYear 2015 - 2,951 itemsYear 2016 - 3,265 itemsYear 2017 - 3,258 itemsYear 2018 - 3,335 itemsYear 2019 - 2,770 itemsScroll right...Scroll left...Download CSVRelated searchespulmonary hypertension newbornchronic thromboembolic pulmonary hypertensionpulmonary hypertension reviewpediatric pulmonary hypertensionpulmonary hypertension dogPMC Images search for pulmonary hypertensionFigureKaplan-Meier Estimates of Survival for Patients With Sickle Cell Disease by Pulmonary Hypertension StatusA, The age-adjusted hazard ratio (AHR) was 3.43 (95% CI, 1.02–11.55; P = .047) for the comparison between patients with pulmonary hypertension documented by right heart catheterization (RHC) and those who did not have pulmonary hypertension documented by RHC; 2.14 (95% CI, 1.25–3.67; P = .006) for patients with pulmonary hypertension vs those who did not undergo RHC (uncatheterized); and 0.62 (95% CI, 0.19–2.03; P = .43) for patients without pulmonary hypertension vs those who did not undergo RHC (uncatheterized). B, The HR was 3.35 (95% CI, 1.01–11.31; P = .04) for the comparison between patients with pulmonary hypertension documented by RHC and those who did not have pulmonary hypertension documented by RHC; 1.73 (95% CI, 1.02–2.93; P = .04) for patients with pulmonary hypertension vs those who did not undergo RHC (uncatheterized); and 0.49 (95% CI, 0.15–1.59; P = .23) for patients without pulmonary hypertension vs those who did not undergo RHC (uncatheterized).Mortality in Adults With Sickle Cell Disease and Pulmonary HypertensionJAMA. ;307(12):1254-1256.Figure 3Kaplan–Meier survival estimates. (A) Each subtype of PHT. (B) Clinical severity of PASP. PAH, pulmonary arterial hypertension; Left heart disease, pulmonary hypertension secondary to left heart disease; Respiratory disease, respiratory-associated pulmonary hypertension; Chronic thromboembolic, chronic thromboembolic pulmonary hypertension; Miscellaneous, miscellaneous pulmonary hypertension; Unknown cause, pulmonary hypertension of unknown cause. Mortality for mild, moderate and severe pulmonary hypertension for all causes of pulmonary hypertension during the period of follow-up. p<0.001 for difference between reference range mild (41–50 mm Hg) compared with moderate or severe. PASP, pulmonary artery systolic pressure.Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohortHeart. 2012 Dec;98(24):1805-1811.Fig 3Kaplan-Meier curves of survival for patients with pulmonary arterial hypertension and patients with pulmonary hypertension due to left heart disease.In the panel a) patients with pulmonary hypertension due to left heart disease are all pooled together, while in the panel b) they are subdivided in three groups according to the diastolic pressure gradient and pulmonary vascular resistance. CpcPH = combined post- and pre-capillary pulmonary hypertension; Interm = intermediate PH-LHD; IpcPH = isolated post-capillary pulmonary hypertension; PAH = pulmonary arterial hypertension; PH-LHD = pulmonary hypertension due to left heart disease.Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary componentPLoS One. 2018;13(6):e0199164.Figure 1Schematic representations of pulmonary hypertension. (A) Schematic cross-sectional representation of a normal pulmonary arteriole and a pulmonary arteriole affected by pulmonary hypertension. (Adapted from Pugliese et al.) (B) Schematic representation of site of initiation of elevated pulmonary arterial pressure of precapillary pulmonary hypertension, postcapillary pulmonary hypertension, and CTEPH. L.V., left ventricle; PH, pulmonary hypertension; R.A., right atrium; R.V., right ventricle.Pathophysiology and treatment of pulmonary hypertension in sickle cell diseaseBlood. 2016 Feb 18;127(7):820-828.See more (10906)...Titles with your search termsMonocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor.[Eur J Pharmacol. 2019]Monocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor.Novelli D, Fumagalli F, Staszewsky L, Ristagno G, Olivari D, Masson S, De Giorgio D, Ceriani S, Affatato R, De Logu F, et al. Eur J Pharmacol. 2019 Nov 4; :172777. Epub 2019 Nov 4.Thyroid Dysfunction in Patients with Pulmonary Artery Hypertension (PAH): The Effect of Therapies Affecting the Prostanoid Pathway.[Lung. 2019]Thyroid Dysfunction in Patients with Pulmonary Artery Hypertension (PAH): The Effect of Therapies Affecting the Prostanoid Pathway.Menon AA, Sahay S, Braverman LE, Farber HW. Lung. 2019 Nov 6; . Epub 2019 Nov 6.Congenital heart disease, pulmonary arterial hypertension and the UK's Drivers and Vehicle Licensing Agency: controversial new guidance.[Pulm Circ. 2019]Congenital heart disease, pulmonary arterial hypertension and the UK's Drivers and Vehicle Licensing Agency: controversial new guidance.Constantine A, Tulloh R, Condliffe R, Clift P, Dimopoulos K. Pulm Circ. 2019 Oct-Dec; 9(4):2045894019882627. Epub 2019 Oct 30.See more...Find related dataDatabase: SelectAssemblyBioProjectBioSampleBioSystemsBooksClinVarConserved DomainsdbGaPdbVarGeneGenomeGEO DataSetsGEO ProfilesHomoloGeneMedGenNucleotideOMIMPMCPopSetProbeProteinProtein ClustersPubChem BioAssayPubChem CompoundPubChem SubstancePubMedSNPSRAStructureTaxonomyOption: Find itemsBest match search information MeSH Terms: hypertension, pulmonary See more... Additional termshypertension; pulmonary hypertension; pulmonary Recent ActivityClearTurn OffTurn Onpulmonary hypertension (63108)PubMedpulmonar hypertension (811)PubMedHypertension, PulmonaryHypertension, PulmonaryIncreased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.<br/>MeSHpulmonar hypertension, adult (2)MeSHpulmonar arterial hypertension (5)MeSHYour browsing activity is empty.Activity recording is turned off.Turn recording back onSee more... You are here: NCBI > Literature > PubMed Support Center <img alt="" src="/stat?jsdisabled=true&amp;ncbi_app=entrez&amp;ncbi_db=pubmed&amp;ncbi_pdid=docsum&amp;ncbi_phid=CE889714DC5ABEA10000000006FA03F6" />

      Filtros para hacer una búsqueda más depurada

    1. las jerarquias de mesh

    2. Medical Subject Headings (MeSH®) in MEDLINE®/PubMed®: A Tutorial

      mesh jerarquía

    1. Considere las ganancias de productividad si la competencia en el lenguaje de programación R, que se puede utilizar para ejecutar análisis estadísticos en una amplia gama de áreas, fuera un hecho

      R

    2. La investigación se volvería más eficiente, como lo hicieron los ferrocarriles después de adoptar un estándar común para el ancho de vía.

      standar